Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.709 GBX | +0,20% | +2,08% | +17,82% |
28/03 | GSK : JP Morgan is negatief | ZD |
28/03 | Amerikaanse FDA keurt medicijn tegen bloedarmoede van Akebia goed | RE |
Vakgebied
Aantal werknemers: 70 212
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Commercial Operations
100,0
%
| 29 324 | 100,0 % | 30 328 | 100,0 % | +3,42% |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
52,2
%
| 14 542 | 49,6 % | 15 820 | 52,2 % | +8,79% |
Rest of World
45,6
%
| 14 087 | 48,0 % | 13 815 | 45,6 % | -1,93% |
United Kingdom
2,3
%
| 695 | 2,4 % | 693 | 2,3 % | -0,29% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01-05-10 |
Julie Brown
DFI | Director of Finance/CFO | 62 | 01-05-23 |
James Ford
CMP | Compliance Officer | - | 01-08-95 |
Amy Altshul
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 01-01-18 | |
Tony Wood
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-17 |
Hal Barron
BRD | Director/Board Member | 62 | 01-01-18 |
David Redfern
PRN | Corporate Officer/Principal | 57 | 01-01-94 |
Frannie DeFranco
PRN | Corporate Officer/Principal | - | 01-09-10 |
Claire Lund
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Julie Brown
DFI | Director of Finance/CFO | 62 | 01-05-23 |
Jonathan Symonds
CHM | Chairman | 66 | 01-09-19 |
Urs Rohner
BRD | Director/Board Member | 65 | 01-01-15 |
Hal Barron
BRD | Director/Board Member | 62 | 01-01-18 |
Vishal Sikka
BRD | Director/Board Member | 57 | 18-07-22 |
Wendy Becker
BRD | Director/Board Member | 58 | 01-10-23 |
Charles Bancroft
BRD | Director/Board Member | 65 | 01-05-20 |
Emma Walmsley
CEO | Chief Executive Officer | 55 | 01-05-10 |
Director/Board Member | 67 | 01-09-22 | |
Jesse Goodman
BRD | Director/Board Member | 72 | 01-01-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 400 765 312 | 4 052 240 131 ( 92,08 %) | 255 885 366 ( 5,815 %) | 92,08 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
127 054 524 | 75.00% | 3 328 359 698 $ | |
HALEON PLC 4.17% | 385 320 110 | 4.17% | 1 615 523 919 $ |
VIR BIOTECHNOLOGY, INC. 6.33% | 8 550 954 | 6.33% | 96 112 723 $ |
GLAXOSMITHKLINE S.A.E 91.20% | 76 161 378 | 91.20% | 94 992 279 $ |
LYELL IMMUNOPHARMA, INC. 12.01% | 30 253 189 | 12.01% | 88 339 312 $ |
263 029 794 | 82.59% | 81 457 697 $ | |
HALEON PAKISTAN LIMITED 85.79% | 100 423 259 | 85.79% | 76 469 299 $ |
WAVE LIFE SCIENCES LTD. 11.75% | 13 983 761 | 11.75% | 67 261 890 $ |
CUREVAC N.V. 7.41% | 16 591 937 | 7.41% | 56 744 425 $ |
DONG-A ST CO., LTD. 8.06% | 707 859 | 8.06% | 39 815 738 $ |
Bedrijfsgegevens
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
GlaxoSmithKline Capital Plc
|
Finance/Rental/Leasing
|
GlaxoSmithKline Biologicals NV
GlaxoSmithKline Biologicals NV BiotechnologyHealth Technology GlaxoSmithKline Biologicals SA manufactures vaccines for diseases such as hepatitis, influenza, rubella, and typhoid fever. Its activities include overall strategy, research and development, clinical trials, regulatory matters, production, quality control, marketing, and distribution. The company has partnership with WHO and UNICEF. GlaxoSmithKline Biologicals was founded in 1945 and is headquartered in Rixensart, Belgium. |
Biotechnology
|
Eskaylab Ltd.
Eskaylab Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 1908, Eskaylab Ltd. is a testing British laboratory company that operates in Middlesex, UK. |
Miscellaneous Commercial Services
|
Horlicks Ltd.
Horlicks Ltd. Beverages: AlcoholicConsumer Non-Durables Horlicks Ltd. manufactures and distributes infant food products. The products it offers are Horlicks traditional, light and light chocolate. The company was founded on December 11, 1925 and is headquartered in Brentford, the United Kingdom. |
Beverages: Alcoholic
|
Novartis Consumer Health SA
Novartis Consumer Health SA Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Novartis Consumer Health SA is a private company based in Basel, Switzerland. |
Pharmaceuticals: Major
|
Glaxo Group Ltd.
Glaxo Group Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1935, Glaxo Group Ltd. is a subsidiary of GSK Plc. The private company is based in Middlesex, UK. At GSK, we unite science, technology and talent to get ahead of disease together. |
Pharmaceuticals: Major
|
GlaxoSmithKline Finance Plc
|
Finance/Rental/Leasing
|
Setfirst Ltd.
Setfirst Ltd. Financial ConglomeratesFinance Part of GSK Plc, Setfirst Ltd. functions as an investment holding British company. The private company is based in Middlesex, UK. |
Financial Conglomerates
|
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The private company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. |
Pharmaceuticals: Major
|
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,82% | 88,25 mld. | |
+33,46% | 701 mld. | |
+26,24% | 570 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 322 mld. | |
+2,95% | 212 mld. | |
+0,74% | 209 mld. | |
-6,05% | 205 mld. | |
-3,61% | 157 mld. |
- Beurs
- Aandelen
- Aandeel GSK plc - London S.E.
- Onderneming GSK plc